SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Buy and Sell Signals, and Other Market Perspectives
SPY 689.17+0.2%Dec 11 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cyrus who wrote (168030)2/12/2022 10:38:26 AM
From: Sdgla  Read Replies (1) of 220068
 
benzinga.com


Moderna, Inc. (NASDAQ: MRNA) CEO Stephane Bancel sold a total of 23,000 shares at an average price of $167.79. The insider received $3.19 million from selling those shares. What’s Happening: Moderna is expected to report Q4 financial results on Thursday, February 24, 2022. What Moderna Does: Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020.

msn.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext